Kidney Cancer Legends Take the Stage to Discuss the Role of Cytoreductive Nephrectomy

Sumanta Kumar Pal | December 13, 2018

The 2018 Society of Urologic Oncology (SUO) Meeting was second to none – an outstanding array of speakers and sessions that addressed virtually every salient point pertaining to renal cell carcinoma (RCC) treatment.  As you can imagine, cytoreductive nephrectomy was a hot topic for discussion – SUO 2018 marked the first large US


Sumanta Kumar Pal, MD

Sumanta (Monty) Kumar Pal, MD, is an internationally recognized leader in the area of genitourinary cancers, including kidney, bladder, and prostate cancer. He is the Co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease. Dr. Pal sits on the Editorial Board for clinical genitourinary cancer and is a reviewer for multiple journals including The Journal of Clinical Oncology, The Journal of Urology, European Urology, and many others.

Library Resources
Evidence based monographs by experts to guide clinical care
Beyond the Abstracts
Author insights on peer reviewed manuscripts
Conference Coverage
Recent data from conferences worldwide

CUOS 2019 Kidney Cancer

SUO 2018 Kidney Cancer

ESMO 2018 Kidney Cancer

AUA 2018 Northeastern Section

FOIU 2018 Kidney Cancer

ASCO 2018 Renal Cancer

AUA 2018 Renal Cancer

EAU 2018 Kidney Cancer

ASCO GU 2018 Renal Cancer

ESMO 2017 Kidney Cancer

ASCO 2017 Renal Cancer

ASCO GU 2017 Kidney Cancer


Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.